DE60012485D1 - Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker - Google Patents

Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker

Info

Publication number
DE60012485D1
DE60012485D1 DE60012485T DE60012485T DE60012485D1 DE 60012485 D1 DE60012485 D1 DE 60012485D1 DE 60012485 T DE60012485 T DE 60012485T DE 60012485 T DE60012485 T DE 60012485T DE 60012485 D1 DE60012485 D1 DE 60012485D1
Authority
DE
Germany
Prior art keywords
salicylamide
lanthanide complexes
ligands
luminescent markers
salicylamidyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60012485T
Other languages
English (en)
Other versions
DE60012485T2 (de
Inventor
Kenneth N Raymond
Stephane Petoud
Seth Cohen
Jide Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of DE60012485D1 publication Critical patent/DE60012485D1/de
Application granted granted Critical
Publication of DE60012485T2 publication Critical patent/DE60012485T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/182Metal complexes of the rare earth metals, i.e. Sc, Y or lanthanide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00Labels used in chemical analysis of biological material
    • G01N2458/40Rare earth chelates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/80Fluorescent dyes, e.g. rhodamine
DE60012485T 1999-02-18 2000-02-18 Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker Expired - Lifetime DE60012485T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US507599 1995-07-26
US12060099P 1999-02-18 1999-02-18
US120600P 1999-02-18
US09/507,599 US6406297B1 (en) 1999-02-18 2000-02-18 Salicylamide-lanthanide complexes for use as luminescent markers
PCT/US2000/004284 WO2000048991A1 (en) 1999-02-18 2000-02-18 Salicylamide-lanthanide complexes for use as luminescent markers

Publications (2)

Publication Number Publication Date
DE60012485D1 true DE60012485D1 (de) 2004-09-02
DE60012485T2 DE60012485T2 (de) 2005-08-18

Family

ID=26818543

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60012485T Expired - Lifetime DE60012485T2 (de) 1999-02-18 2000-02-18 Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker

Country Status (9)

Country Link
US (4) US6406297B1 (de)
EP (1) EP1154991B1 (de)
JP (1) JP4943585B2 (de)
AT (1) ATE272049T1 (de)
AU (1) AU762754B2 (de)
CA (1) CA2371818C (de)
DE (1) DE60012485T2 (de)
DK (1) DK1154991T3 (de)
WO (1) WO2000048991A1 (de)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749811B2 (en) 1998-04-28 2004-06-15 The Johns Hopkins University Molecularly imprinted polymer solution anion sensor
AU5142899A (en) * 1999-02-17 2000-09-04 Resolution Pharmaceuticals Inc. Immobilized labeling compounds and methods
JP4943585B2 (ja) * 1999-02-18 2012-05-30 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発光マーカーとして用いるためのサリチルアミド−ランタニド錯体
CA2371816C (en) * 1999-02-18 2010-04-27 The Regents Of The University Of California Phthalamide-lanthanide complexes for use as luminescent markers
DE19936997B4 (de) * 1999-08-02 2007-06-14 Biolitec Ag Verfahren zur Applikation von Photosensibilisatoren (PS) mittels Multiplikatoren in der photodymamischen Therapie
US7166719B2 (en) 2002-06-27 2007-01-23 Health Research, Inc. Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
EP1365745A2 (de) * 2001-02-15 2003-12-03 King Pharmaceuticals, Inc. Stabilisierte pharmazeutische und schilddrüsenhormon-zusammensetzungen und herstellungsverfahren
AU2002365421A1 (en) 2001-07-10 2003-09-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting the activation state of the multiple proteins in single cells
US7393656B2 (en) * 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US6846915B2 (en) * 2001-08-13 2005-01-25 The Regents Of The University Of California Hydroxypyridonate and hydroxypyrimidinone chelating agents
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030181524A1 (en) * 2001-10-29 2003-09-25 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
AU2003249742A1 (en) * 2002-07-02 2004-01-23 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
ES2440284T3 (es) * 2002-11-14 2014-01-28 Thermo Fisher Scientific Biosciences Inc. ARNip dirigido a tp53
US20040161737A1 (en) * 2003-02-14 2004-08-19 Yang Dan-Hui D. Novel luminescent metal chelates and methods for their detection
CA2520538C (en) 2003-03-31 2014-04-29 F. Hoffmann-La Roche Ag Compositions and methods for detecting certain flaviviruses, including members of the japanese encephalitis virus serogroup
BRPI0410635A (pt) 2003-05-23 2006-06-13 Epix Pharm Inc isÈmeros enriquecidos e opticamente puros de ligantes de quelação e agentes de contraste
US7910376B2 (en) * 2003-05-27 2011-03-22 Alexander Menzel Method for detecting trace explosives using photoluminescence
DK1706452T3 (da) 2003-12-30 2009-01-19 Univ California Office Of The Aromatiske triamid-lanthanidkomplekser
US7939251B2 (en) 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer
US20070009980A1 (en) * 2004-06-01 2007-01-11 Applera Corporation Continuous fluorogenic analyte assays with dendritic amplification of signal
CN1707244B (zh) * 2004-06-11 2010-04-07 中国科学院大连化学物理研究所 一种二氧化钛纳米铕荧光探针
JP5243684B2 (ja) * 2004-11-04 2013-07-24 ユー・ディー・シー アイルランド リミテッド 有機金属錯体、発光性固体、有機el素子及び有機elディスプレイ
US20080241943A1 (en) * 2004-11-19 2008-10-02 The Scripps Research Institute Subnanomolar Precipitator of Thiophilic Metals
US20060275217A1 (en) * 2005-05-06 2006-12-07 Caravan Peter D Chemical exchange saturation transfer contrast agents
US20100291689A1 (en) * 2006-03-21 2010-11-18 Board Of Supervisors Of Louisiana State University & Agricultural And Mechanical College Lanthanide Complexes as Fluorescent Indicators for Neutral Sugars and Cancer Diagnosis
EP2044090B1 (de) 2006-07-10 2015-04-08 The Regents of The University of California Lumineszente 1-hydroxy-2-pyridinon-chelate aus lanthanoiden
JP5352460B2 (ja) * 2006-08-15 2013-11-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ルミネッセント大環状ランタニド錯体
EP2114905B1 (de) * 2007-01-25 2015-04-15 Lumiphore, Inc. Mehrfarbige zeitgesteuerte fluorophore auf basis makrozyklischer lanthanid-komplexe
EP2860247A1 (de) 2007-08-21 2015-04-15 Nodality, Inc. Diagnose-, Prognose- und Behandlungsverfahren
FR2934684B1 (fr) 2008-07-31 2012-11-16 Cis Bio Int Methode de detection de l'internalisation de proteines membranaires.
US20100151591A1 (en) * 2008-10-31 2010-06-17 Butlin Nathaniel G Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
US8309306B2 (en) * 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
WO2010075003A1 (en) * 2008-12-16 2010-07-01 The University Of Akron Lanthanide ion complexes and imaging method
US20100233733A1 (en) * 2009-02-10 2010-09-16 Nodality, Inc., A Delaware Corporation Multiple mechanisms for modulation of the pi3 kinase pathway
US9273059B2 (en) 2009-08-24 2016-03-01 Lumiphore, Inc. Macrocyclic HOPO chelators
US9459246B2 (en) 2009-09-08 2016-10-04 Nodality, Inc. Induced intercellular communication
EP2516407A4 (de) 2009-12-24 2013-06-12 Lumiphore Inc Radiopharmazeutische komplexe
JP5958339B2 (ja) 2010-06-07 2016-07-27 コニカミノルタ株式会社 近接場増強蛍光センサチップ
US9134235B2 (en) 2010-08-17 2015-09-15 Konica Minolta, Inc. SPFS sensor equipped with mechanism purifying non-specifically adsorptive contaminants
EP2616817A4 (de) 2010-09-15 2014-04-09 Endacea Inc Verfahren zur verwendung und kit zur messung von lipopolysacchariden mit einem zeitgesteuerten assay auf fluoreszenzbasis
DE102011001368B4 (de) * 2011-03-17 2013-01-31 Bundesanstalt für Materialforschung und -Prüfung (BAM) Lanthanoid-Chelate enthaltende Partikel, deren Herstellung sowie deren Verwendung in der Bioanalytik
FR2977674B1 (fr) 2011-07-06 2015-08-14 Cisbio Bioassays Methode amelioree de detection et/ou de quantification d'un analyte present a la surface d'une cellule
WO2013015282A1 (ja) 2011-07-28 2013-01-31 コニカミノルタホールディングス株式会社 アナライト量の測定方法およびspfs用装置
US9944657B2 (en) 2011-08-19 2018-04-17 Radiometer Turku Oy Luminescent lanthanide chelates having three chromophores an their use
CN103890137B (zh) * 2011-08-19 2016-08-24 Dhr芬兰公司 具有三个发色团的发光镧系元素螯合物及其用途
FR2980271B1 (fr) 2011-09-16 2013-10-11 Cisbio Bioassays Procede de determination de la glycosylation d'un anticorps
US9518186B2 (en) 2011-12-22 2016-12-13 Radiometer Turku Oy Luminescent lanthanide chelates with enhanced excitation properties
EP2607884A1 (de) * 2011-12-23 2013-06-26 Essilor International (Compagnie Générale d'Optique) Brillenglasbewertung hinsichtlich des Schutzes gegen UV-Gefahren
US20150185150A1 (en) 2012-02-22 2015-07-02 Cisbio Bioassays Method for normalizing the luminescence emitted by a measuring medium
FR2988174B1 (fr) 2012-03-19 2014-04-25 Cisbio Bioassays Procede de determination de la capacite d'un anticorps a maintenir des cellules a proximite l'une de l'autre
US9439984B2 (en) 2012-05-31 2016-09-13 The Regents Of The University Of California Macrocycles
EP2920157B1 (de) 2012-11-16 2019-09-11 Lumiphore, Inc. Di-macrocyclen
WO2014147288A1 (en) 2013-01-31 2014-09-25 Kaivogen Oy Luminescent triazacyclononane-based lanthanide chelate complexes as labelling reagents
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
US9388110B2 (en) * 2013-12-12 2016-07-12 Saudi Arabian Oil Company Liquid phase oxidation of aromatic feedstocks with manganate recycling to produce carboxylic acids
DE102014203266B4 (de) 2014-02-24 2018-07-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Zusammensetzung mit FRET-Paar in definierter Geometrie
ES2898633T3 (es) 2014-04-09 2022-03-08 Lumiphore Inc Macrociclos
WO2016106241A1 (en) 2014-12-22 2016-06-30 Lumiphore, Inc. Functionalized linear ligands and complexes thereof
FR3032797B1 (fr) 2015-02-13 2017-03-03 Cisbio Bioassays Procede de quantification d'une proteine d'interet presente dans un echantillon biologique
US11248269B2 (en) 2015-03-05 2022-02-15 University Of New Hampshire Methods and compositions for identifying pathogenic vibrio parahaemolyticus
JP2018523671A (ja) 2015-08-13 2018-08-23 ザ ジェネラル ホスピタル コーポレイション 分子mrイメージング用マンガン系キレートコンジュゲート
CN106010502B (zh) * 2015-11-24 2019-03-01 河北科技大学 一种具有氟离子传感性能的稀土介孔杂化发光材料的制备方法
JP6924780B2 (ja) 2016-06-09 2021-08-25 ラジオメーター・トゥルク・オサケユキチュア 結合アッセイのバックグラウンド遮断剤
CN106317096B (zh) * 2016-08-19 2019-05-28 华南师范大学 一种邻菲罗啉并咪唑型稀土配位分子基探针及其制备方法和应用
EP3507592A4 (de) 2016-09-02 2020-01-15 Lumiphore Inc. Makrocyclische liganden mit hängenden chelatbildenden gruppen und komplexe davon
WO2018130988A1 (en) 2017-01-12 2018-07-19 Nestec S.A. Cryptate derivatives and their use as luminescent lanthanide complexes
CN110691852A (zh) * 2017-05-31 2020-01-14 豪夫迈·罗氏有限公司 Alk、ret和ros融合物的多重pcr检测
FR3069644A1 (fr) 2017-07-28 2019-02-01 Cisbio Bioassays Methode pour mesurer la modulation de l'activation d'un recepteur couple a une proteine g
ES2948008T3 (es) 2017-10-02 2023-08-25 Otsuka Pharma Co Ltd Método para detectar analito
EP3752819B1 (de) 2018-02-15 2023-08-09 ProciseDx Inc. Analysator
EP3752289A1 (de) 2018-02-15 2020-12-23 ProciseDx Inc. Testküvette
EP3762042A4 (de) 2018-03-07 2021-12-22 Lumiphore, Inc. Makrocyclische liganden mit hängenden chelatbildenden gruppen und komplexe davon
EP3591024B1 (de) 2018-07-05 2021-01-13 Université de Strasbourg Ultrahelle lumineszierende lanthanid-nanopartikel enthaltend terbium mit längerer lebensdauer im angeregten zustand
FR3084365B1 (fr) 2018-07-27 2020-10-23 Cisbio Bioassays Anticorps a domaine unique qui se lient a la proteine g alpha
WO2020102556A1 (en) 2018-11-15 2020-05-22 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods of prognosis and classification for preeclampsia
FR3092172B1 (fr) 2019-01-30 2021-02-12 Cisbio Bioassays Méthode pour mesurer la modulation de l’activation d’un récepteur couplé à une protéine G avec des analogues du GTP
WO2020232262A1 (en) 2019-05-16 2020-11-19 Procisedx Inc. Assay detection methods for vcam-1 and calprotectin
JP2022532385A (ja) 2019-05-16 2022-07-14 プロサイセデクス インコーポレイティド 血中のVCAM-1及びα2-マクログロブリンの検出のためのアッセイ方法
JP2022534227A (ja) 2019-05-23 2022-07-28 プロサイセデクス インコーポレイティド ヒト血清アルブミン、ビタミンd、c反応性タンパク質、及び抗トランスグルタミナーゼ自己抗体の検出のためのアッセイ方法
JPWO2021111820A1 (de) 2019-12-06 2021-06-10
EP4073066A4 (de) * 2019-12-13 2023-12-27 University of Pittsburgh - of the Commonwealth System of Higher Education Lanthanidverbindungen für die lumineszenz-einschalt-detektion
WO2021242725A1 (en) 2020-05-28 2021-12-02 Procisedx Inc. Predetermined calibration curve
EP4343775A1 (de) 2022-09-22 2024-03-27 SurgeCare Verfahren zur bestimmung eines medizinischen ergebnisses für eine person, zugehöriges elektronisches system und computerprogramm

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2588265B3 (fr) * 1985-10-04 1988-01-15 Inst Francais Du Petrole Procede d'adoucissement d'une charge d'hydrocarbures contenant des produits soufres
SE8703682L (sv) * 1987-09-24 1989-03-25 Wallac Oy Homogen bestaemningsmetod som utnyttjar affinitetsreaktioner
AU9163491A (en) 1990-12-17 1992-07-22 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Derivatized tris-catechol chelating agents
DE4222255A1 (de) 1992-07-07 1994-01-13 Bayer Ag Fotochemische Markierung von Nukleinsäuren mit Europiumchelat-Reagenzien und ihre Verwendung in Gensondentestsystemen
DE19525924A1 (de) * 1995-07-04 1997-01-09 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE19728021A1 (de) * 1997-07-01 1999-01-07 Clariant Gmbh Metall-Komplexe als Bleichaktivatoren
CA2371816C (en) * 1999-02-18 2010-04-27 The Regents Of The University Of California Phthalamide-lanthanide complexes for use as luminescent markers
JP4943585B2 (ja) * 1999-02-18 2012-05-30 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発光マーカーとして用いるためのサリチルアミド−ランタニド錯体

Also Published As

Publication number Publication date
CA2371818C (en) 2009-01-06
US20060286567A1 (en) 2006-12-21
US7404912B2 (en) 2008-07-29
DK1154991T3 (da) 2004-11-22
ATE272049T1 (de) 2004-08-15
US20080293155A1 (en) 2008-11-27
AU762754B2 (en) 2003-07-03
EP1154991A1 (de) 2001-11-21
DE60012485T2 (de) 2005-08-18
US7018850B2 (en) 2006-03-28
AU3600600A (en) 2000-09-04
JP2003535812A (ja) 2003-12-02
EP1154991B1 (de) 2004-07-28
WO2000048991A1 (en) 2000-08-24
US20030027189A1 (en) 2003-02-06
US6406297B1 (en) 2002-06-18
JP4943585B2 (ja) 2012-05-30
CA2371818A1 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
DE60012485D1 (de) Salicylamid-lanthanid komplexe zur verwendung als lumineszenzmarker
ATE285394T1 (de) Phthalamid-lanthanid komplexe zur verwendung als lumineszenzmarker
ATE277058T1 (de) Polyazomacrocyclofluoromonoalkylphosphensäure, ihre komplexe zur verwendung als kontrastmittel
MXPA03006055A (es) Nuevos compuestos de n-fenilpirrolbisfosfano y sus complejos de metal.
ATE227297T1 (de) 2-pyridylmethylen-polyazamacrocyclophosphonsäur n,ihre komplexe und derivate zur verwendung als kontrastmittel
ATE407176T1 (de) Aromatische triamid-lanthanid-komplexe
ATE388157T1 (de) Neue phosphitverbindungen und deren rh-komplexe
DE69807558T2 (de) Chelatkomplexe paramagnetischer Metalle mit niedriger Toxizität
DE60140286D1 (de) Legiertes Stahlpulver für pulvermetallurgisches Verfahren
ATE248849T1 (de) Verbrückte metallkomplexe
CA2457584A1 (en) Enhancing solubility of iron amino acid chelates and iron proteinates
ATE233762T1 (de) Bicyclische polyamiosaure metallkomplexe, verfahren zu ihrer herstellung und ihre verwendung für medizinische bilderzeugung
DE69822162D1 (de) Neue tetrazolderivate
DE60110558D1 (de) Konjugate von gallensäure mit metallbindenden chelatverbdingungen und die verwendung davon
DE60014267D1 (de) Magnet aus seltenen erdmetallen für mri abtaster hergestellt aus aufbereitetem, pr-nd enthaltendem erzresiduum
BRPI0410635A (pt) isÈmeros enriquecidos e opticamente puros de ligantes de quelação e agentes de contraste
DK1218385T3 (da) Carbonmonoxidkilde til fremstilling af overgangsmetalcarbonylkomplekser
ATE332356T1 (de) Verwendung von metallkomplexverbindungen als oxidationskatalysatoren
NO970342D0 (no) Makrosykliske chelanter, deres chelater og anvendelse derav innen det diagnostiske felt
DE59709024D1 (de) Pseudopolyrotaxane
ES2187800T3 (es) Reactivos formadores de complejos con compuestos boronicos y complejos correspondientes.
YU36104A (sh) Kristalna struktura fosfodiesteraza 5 i njihova upotreba
ATE271395T1 (de) Konjugate von gallensäure derivaten und metallionenchelatkomplexen und ihre verwendung zur beurteilung der microvaskulären permeabilität
ATE360021T1 (de) Neue benzonaphthyridine
ATE273986T1 (de) Eine substanz oder eine zusammensetzung zur krebsbehandlung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition